MyFinsight
Home
Blog
About
Back
Cash Flow
SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc. (SLS)
source: myfinsight.com
Proceeds from the
exercise of common stock...
$82,918K
(1659.72%↑ Y/Y)
Proceeds from employee
stock purchases
$66K
(37.50%↑ Y/Y)
Net cash provided by
financing activities
$82,984K
(198.39%↑ Y/Y)
Net increase in
cash, cash...
$66,550K
(483.21%↑ Y/Y)
Canceled cashflow
$16,434K
Non-cash stock-based
compensation
$1,813K
(80.22%↑ Y/Y)
Accrued expenses and
other current...
$378K
(111.17%↑ Y/Y)
Non-cash lease expense
$307K
(3.72%↑ Y/Y)
Accounts payable
$138K
(184.15%↑ Y/Y)
Net cash used in
operating activities
-$16,434K
(-0.21%↓ Y/Y)
Canceled cashflow
$2,636K
Net loss
-$18,012K
(-45.09%↓ Y/Y)
Prepaid expenses and
other assets
$740K
(-48.00%↓ Y/Y)
Operating lease
liabilities
-$318K
(0.00%↑ Y/Y)
Back